Distraction. Yes, IMO that is what CVSI is doing right before they come out with those 4th qt and year end numbers. Those numbers should be the focus!
But let’s entertain the 007 patent. Currently the 007 patent is sitting on a shelve collecting dust.
REF. from the 10Q “On May 19, 2020, the USPTO issued a patent pertaining to CVSI-007”
So, it’s been sitting for 3 years.
So, how’s the funding going for that
REF 10Q R&D expense decreased to $0.3 million during the nine months ended September 30, 2022 compared to $0.8 million in the first nine months of 2021. The decrease is mostly related to lower R&D spend in our specialty pharmaceutical segment.
Not exactly lighting it up there are they.
So whats the game plan, from the 10 Q: " We expect to realize revenue from our consumer products business segment to fund our working capital needs. In addition, we will be dependent, for the near future, on additional investment capital to fund operations, growth initiatives and to continue to make and implement strategic cost reductions. Also, in order to fund our pharmaceutical product development efforts, we will need to raise additional capital either through the issuance of equity and/or the issuance of debt. In the event we are unable to fund our drug development efforts, we may need to curtail, partner or delay such activity."
Well sure, I expect them to raise revenue from our consumer products business segment as well but for the last 3 years all they had were losses.
Good thing they have that 600 million shares to dilute with, cause I don’t think they will be getting the funding for this that they would need.
Still, that doesn’t leave much for the dreamers. Ok let’s go with this, all slanted to the positive. They find a partner that will pick up all costs, free ride, split the profits when done. They start the pretrial for 007 today! They pass 1 then 2 then 3 phases. Normally it would take 3 years plus, I’m going to knock it down to two. They build the product, set up the pipeline, and start the distribution nation wide at no cost to them. you say 6mo to a year to do it, nope going to do all that in a week. Product starts selling. It’s as simple as that.
Now all we have to do is see if they can make it past 2023,24, and into 2025. Find that partner and away we go.
The 4th qt and year end comes out next WED. Then reality kicks in. And the distraction is over. IMO
Bearish
